PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-1875

  1. 1,064 Posts.
    lightbulb Created with Sketch. 532
    Does anyone have more info on the Japanese trials, or (upcoming) peer reviewed articles?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.